Farlow M, Ghetti B, Dlouhy S, Giaccone G, Bugiani O, Tagliavini F, Wagner S
Department of Neurology, Indiana University School of Medicine, Indianapolis 46202-5124.
Neurology. 1994 Aug;44(8):1508-10. doi: 10.1212/wnl.44.8.1508.
We studied levels of amyloid beta-protein precursor (beta PP) in CSF from four patients affected with Gerstmann-Sträussler-Scheinker disease and one asymptomatic gene-carrier from an Indiana kindred. Levels of beta PP were decreased in all affected patients with the lowest levels occurring in the clinically most severely affected patients. Correlation of neuropathology with CSF data in three patients suggested that low beta PP in CSF may be associated with beta PP accumulation in neurites surrounding cortical and cerebellar amyloid deposits.
我们研究了4例患有格斯特曼-施特劳斯勒-谢inker病的患者以及1名来自印第安纳州家族的无症状基因携带者脑脊液中β淀粉样蛋白前体(βPP)的水平。所有患病患者的βPP水平均降低,临床症状最严重的患者βPP水平最低。对3例患者的神经病理学与脑脊液数据的相关性分析表明,脑脊液中低水平的βPP可能与皮质和小脑淀粉样沉积物周围神经突中βPP的积累有关。